作者:Karen F. Marlowe、Michael F. Chicella
DOI:10.1592/phco.22.7.484.33675
日期:2002.4
Sickle cell disease affects 70,000 Americans who experience an average of 0.8 painful episodes each year. The pathophysiology of sickle cell pain is not completely understood. The disease is characterized by both acute and chronic pain syndromes. Patients with sickle cell pain often encounter barriers to receiving appropriate care, including lack of continuity of care and perceived opiate addiction. Studies describing pharmacotherapy for sickle cell pain have been primarily retrospective and uncontrolled. In analyzing the available literature regarding pathophysiology, assessment, and treatment of sickle cell pain, we found a need for increased practitioner education and intervention to improve the level of care provided to patients with this disease.
镰状细胞疾病影响着70,000名美国人,他们每年平均经历0.8次疼痛发作。镰状细胞疼痛的病理生理学尚未完全 understood。该疾病的特点是急性和慢性疼痛综合征并存。镰状细胞疼痛的患者在获得适当护理时常常遇到障碍,包括缺乏连续护理和被认为的鸦片类药物上瘾。关于镰状细胞疼痛的药物治疗的研究主要是回顾性和无对照的。在分析现有文献关于镰状细胞疼痛的病理生理学、评估和治疗时,我们发现有必要加强从业人员的教育和干预,以提高对该疾病患者提供的护理水平。